GSK Q3 2026 Earnings Call Transcript
GSK (NYSE:GSK) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Stocks · News reference
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Analyst ratings and news for high-yield healthcare stocks Medtronic (3.06%), Smith & Nephew (2.74%) and GSK (3.65%).
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
GSK Reports Strong Third Quarter 2026 Financial Results
GSK reported third-quarter 2026 results, with core earnings per share of 54.6 pence, exceeding analyst consensus of 50.4 pence, driven by strong performance in its Specialty Medicines portfolio.
GSK Plans to Nearly Double Clinical-Stage Cancer Drug Pipeline in 2027
GSK has announced plans to significantly expand its oncology research and development efforts by nearly doubling the number of cancer drug candidates in clinical trials by 2027.
GSK Announces Director/PDMR Shareholding Transaction
GSK reported that Maya Martinez-Davis, President of US operations, acquired 9.324 notional American Depositary Shares (ADS) on October 22, 2026.
Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact
Boston Scientific (BSX) stock fell 6% after the medical device maker cut its Q4 sales and full-year EPS guidance due to ongoing disruptions from an August cyberattack. The company estimated the eight-day cyberattack cost it 300 basis points in sales growth and $0.07 in adjusted EPS. Management expects a slow recovery with 2027 projected as the trough year, though the stock now trades at a relatively low 13x forward earnings multiple.
Medtronic Opens Applications for Second Cohort of Spark Scholarship
Medtronic has launched the application process for its second annual Spark Scholarship, a global program providing financial and developmental support to students pursuing careers in health technology.